These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 9627139)
1. Has hospital mortality from acute myocardial infarction been markedly reduced since the introduction of thrombolytics and aspirin? European Secondary Prevention Study Group. Reikvam A; Abdelnoor M; Sivertssen E J Intern Med; 1998 Apr; 243(4):259-63. PubMed ID: 9627139 [TBL] [Abstract][Full Text] [Related]
2. Hospital mortality from acute myocardial infarction has been modestly reduced after introduction of thrombolytics and aspirin: results from a new analytical approach. European Secondary Prevention Study Group. Reikvam A; Aursnes I J Clin Epidemiol; 1999 Jul; 52(7):609-13. PubMed ID: 10391653 [TBL] [Abstract][Full Text] [Related]
3. [The effect of acetylsalicylic acid and streptokinase on the restoration of systolic heart function in patients after a myocardial infarct]. Chubuchna II Lik Sprava; 1997; (6):48-52. PubMed ID: 9589926 [TBL] [Abstract][Full Text] [Related]
4. New recommendations from the 1999 American College of Cardiology/American Heart Association acute myocardial infarction guidelines. Spinler SA; Hilleman DE; Cheng JW; Howard PA; Mauro VF; Lopez LM; Munger MA; Gardner SF; Nappi JM Ann Pharmacother; 2001 May; 35(5):589-617. PubMed ID: 11346067 [TBL] [Abstract][Full Text] [Related]
5. [Check list for the use of thrombolytics and other drugs in acute myocardial infarction]. Hovland A; Nielsen EW Tidsskr Nor Laegeforen; 2000 Feb; 120(6):662-4. PubMed ID: 10806876 [TBL] [Abstract][Full Text] [Related]
6. [Use of thrombolytic agents and other drugs in acute myocardial infarction]. Reikvam A Tidsskr Nor Laegeforen; 1996 May; 116(14):1671-4. PubMed ID: 8658433 [TBL] [Abstract][Full Text] [Related]
7. Dynamics of left ventricular thrombi in patients with acute anterior myocardial infarction treated with thrombolytics. Mooe T; Teien DE; Karp KH; Eriksson P Coron Artery Dis; 1995 Sep; 6(9):703-7. PubMed ID: 8747875 [TBL] [Abstract][Full Text] [Related]
8. [ln-hospital mortality after ST-segment elevation myocardial infarction according to reperfusion therapy]. Prieto JC; Sanhueza C; Martínez N; Nazzal C; Corbalán R; Cavada G; Lanas F; Bartolucci J; Campos P; Rev Med Chil; 2008 Feb; 136(2):143-50. PubMed ID: 18483666 [TBL] [Abstract][Full Text] [Related]
9. Streptokinase-induced hypotension has no detrimental effect on patients with thrombolytic treatment for acute myocardial infarction. A substudy of the Romanian Study for Accelerated Streptokinase in Acute Myocardial Infarction (ASK-ROMANIA). Tatu-Chiţoiu G; Teodorescu C; Dan M; Guran M; Căpraru P; Istrăţescu O; Tatu-Chiţoiu A; Bumbu A; Chioncel V; Arvanitopol S; Dorobanţu M Rom J Intern Med; 2004; 42(3):557-73. PubMed ID: 16366130 [TBL] [Abstract][Full Text] [Related]
10. One-year mortality after acute myocardial infarction prior to and after the implementation of a widespread use of thrombolysis and aspirin. Experiences from the community of Göteborg, Sweden. Herlitz J; Hartford M; Karlson BW; Dellborg M; Källström G; Karlsson T Cardiology; 1998 Mar; 89(3):216-21. PubMed ID: 9570437 [TBL] [Abstract][Full Text] [Related]
11. Strategies for the management of acute myocardial infarction: selecting patients for thrombolytic therapy. Talbert RL Am J Health Syst Pharm; 1997 Nov; 54 Suppl 1():S9-16. PubMed ID: 9397232 [TBL] [Abstract][Full Text] [Related]
12. Patterns of practice for acute myocardial infarction in a population from ten countries. Venturini F; Romero M; Tognoni G Eur J Clin Pharmacol; 1999 Jan; 54(11):877-86. PubMed ID: 10027664 [TBL] [Abstract][Full Text] [Related]
13. Mortality benefit of immediate revascularization of acute ST-segment elevation myocardial infarction in patients with contraindications to thrombolytic therapy: a propensity analysis. Grzybowski M; Clements EA; Parsons L; Welch R; Tintinalli AT; Ross MA; Zalenski RJ JAMA; 2003 Oct; 290(14):1891-8. PubMed ID: 14532318 [TBL] [Abstract][Full Text] [Related]
14. A randomized factorial trial of reperfusion strategies and aspirin dosing in acute myocardial infarction. The DUCCS-II Investigators. O'Connor CM; Meese RB; McNulty S; Lucas KD; Carney RJ; LeBoeuf RM; Maddox W; Bethea CF; Shadoff N; Trahey TF; Heinsimer JA; Burks JM; O'Donnell G; Krucoff MW; Califf RM Am J Cardiol; 1996 Apr; 77(10):791-7. PubMed ID: 8623729 [TBL] [Abstract][Full Text] [Related]
15. Design of a placebo-controlled clinical trial of long-acting diltiazem and aspirin versus aspirin alone in patients receiving thrombolysis with a first acute myocardial infarction. Incomplete Infarction Trial of European Research Collaborators Evaluating Prognosis Post-Thrombolysis (diltiazem) (INTERCEPT) Research Group. Boden WE; Scheldewaert R; Walters EG; Whitehead A; Coltart DJ; Santoni JP; Belgrave G; Starkey IR Am J Cardiol; 1995 Jun; 75(16):1120-3. PubMed ID: 7762497 [TBL] [Abstract][Full Text] [Related]
16. Selection factors for the use of thrombolytic treatment in acute myocardial infarction: a population based study of current practice in the United Kingdom. The European Secondary Prevention Study Group. Ketley D; Woods KL Br Heart J; 1995 Sep; 74(3):224-8. PubMed ID: 7547014 [TBL] [Abstract][Full Text] [Related]
17. Present treatment of acute myocardial infarction in patients over 75 years--data from the Berlin Myocardial Infarction Registry (BHIR). Schuler J; Maier B; Behrens S; Thimme W Clin Res Cardiol; 2006 Jul; 95(7):360-7. PubMed ID: 16741630 [TBL] [Abstract][Full Text] [Related]
18. Recombinant hirudin (lepirudin) for the improvement of thrombolysis with streptokinase in patients with acute myocardial infarction: results of the HIT-4 trial. Neuhaus KL; Molhoek GP; Zeymer U; Tebbe U; Wegscheider K; Schröder R; Camez A; Laarman GJ; Grollier GM; Lok DJ; Kuckuck H; Lazarus P J Am Coll Cardiol; 1999 Oct; 34(4):966-73. PubMed ID: 10520777 [TBL] [Abstract][Full Text] [Related]
20. Extent of early ST segment elevation resolution: a strong predictor of outcome in patients with acute myocardial infarction and a sensitive measure to compare thrombolytic regimens. A substudy of the International Joint Efficacy Comparison of Thrombolytics (INJECT) trial. Schröder R; Wegscheider K; Schröder K; Dissmann R; Meyer-Sabellek W J Am Coll Cardiol; 1995 Dec; 26(7):1657-64. PubMed ID: 7594100 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]